Literature DB >> 11559422

Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.

H Wu1, E Connick, D R Kuritzkes, A Landay, J Spritzler, B Zhang, G T Spear, H Kessler, M M Lederman.   

Abstract

This exploratory analyses characterizes patterns of lymphocyte recovery in HIV-1-infected patients treated with highly active antiretroviral therapy (HAART) and investigates their relationship with baseline indices and virologic responses. We modeled kinetics of total CD4+ lymphocytes, as well as naive (CD45RA+ CD62L+), and memory (CD45RA- CD45RO+) subsets in 48 patients treated with AZT/3TC/Ritonavir for 48 weeks in ACTG protocol 315. Cell kinetic indices were estimated by nonlinear regression methods and were correlated with baseline factors and virologic responses. Five different kinetic patterns were identified, including biphasic growth, growth-plateau, growth-depletion, decay-recovery, and biphasic decay. Although overall mean lymphocyte responses showed a biphasic increase in cell number, a careful investigation reveals that only one-third of patients actually followed the biphasic growth pattern in CD4+ cell response, while 44% of 48 patients from this study followed the growth-depletion pattern. CD4+ cell recovery during the first phase and the 48-week study period were negatively correlated with baseline CD4+ cell counts, and positively correlated with baseline viral load. Memory CD4+ cell recovery during the first phase was also negatively correlated with baseline memory CD4+ and total CD4+ cell number, but the recovery rate of memory CD4+ cells during the second phase was positively correlated with baseline CD4+ cell number. Patients with a decay in CD4+ cell count during treatment were more likely to have experienced virological rebound (58%) than patients with nondecay patterns (24%). The rate and magnitude of the absolute increase in total CD4+ and memory CD4+ cell number (but not naive CD4+ cells) during the second phase were lower in patients with viral rebound compared with patients with persistent viral suppression. These results show that the kinetics of lymphocyte reconstitution in response to potent antiretroviral therapy in individual patients vary considerably from the "classic" biphasic increase that characterizes the mean or median response pattern. Pattern analysis of lymphocyte kinetics may be useful for testing relationships among factors that modulate the response to treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559422     DOI: 10.1089/088922201750461285

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy.

Authors:  Akihiko Saitoh; Kumud K Singh; Sharsti Sandall; Christine A Powell; Terrence Fenton; Courtney V Fletcher; Karen Hsia; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

2.  Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).

Authors:  R Oyomopito; M P Lee; P Phanuphak; P L Lim; R Ditangco; J Zhou; T Sirisanthana; Y M A Chen; S Pujari; N Kumarasamy; S Sungkanuparph; C K C Lee; A Kamarulzaman; S Oka; F J Zhang; C V Mean; T Merati; G Tau; J Smith; P C K Li
Journal:  HIV Med       Date:  2010-03-21       Impact factor: 3.180

3.  Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy.

Authors:  Hemant Kulkarni; Jason F Okulicz; Greg Grandits; Nancy F Crum-Cianflone; Michael L Landrum; Braden Hale; Glenn Wortmann; Edmund Tramont; Michael Polis; Matthew Dolan; Alan R Lifson; Brian K Agan; Sunil K Ahuja; Vincent C Marconi
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

4.  Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART).

Authors:  E Ruiz-Mateos; A Rubio; A Vallejo; R De la Rosa; A Sanchez-Quijano; E Lissen; M Leal
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 5.  The lymph node in HIV pathogenesis.

Authors:  Michael M Lederman; Leonid Margolis
Journal:  Semin Immunol       Date:  2008-07-14       Impact factor: 11.130

6.  Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy.

Authors:  Sinead E Morris; Luise Dziobek-Garrett; Renate Strehlau; Juliane Schröter; Stephanie Shiau; Anet J N Anelone; Maria Paximadis; Rob J de Boer; Elaine J Abrams; Caroline T Tiemessen; Louise Kuhn; Andrew J Yates
Journal:  J Acquir Immune Defic Syndr       Date:  2020-10-01       Impact factor: 3.731

7.  Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study.

Authors:  Livio Azzoni; Andrea S Foulkes; Cynthia Firnhaber; Xiangfan Yin; Nigel J Crowther; Deborah Glencross; Denise Lawrie; Wendy Stevens; Emmanouil Papasavvas; Ian Sanne; Luis J Montaner
Journal:  J Int AIDS Soc       Date:  2011-07-29       Impact factor: 5.396

8.  Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings.

Authors:  Danho Pascal Abrogoua; Brou Jerome Kablan; Boua Alexis Thierry Kamenan; Gilles Aulagner; Konan N'guessan; Christian Zohoré
Journal:  Patient Prefer Adherence       Date:  2012-03-23       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.